CERO THERAPEUTICS HOLDINGS, INC. Earnings Per Share (Basic)
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Earnings Per Share (Basic) of -$0.70 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- CERO THERAPEUTICS HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.70.
- CERO THERAPEUTICS HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.20.
- CERO THERAPEUTICS HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$9.10.
- CERO THERAPEUTICS HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$61.71.
- CERO THERAPEUTICS HOLDINGS, INC. earnings per share, basic for fiscal 2023 was -$1248.64.
| Period end | Earnings Per Share, Basic 1 month | Earnings Per Share, Basic 1 month as first filed | Earnings Per Share, Basic 2 month | Earnings Per Share, Basic 2 month as first filed | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 5 month | Earnings Per Share, Basic 5 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 8 month | Earnings Per Share, Basic 8 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 11 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.70 10-Q · filed 2026-08-14 | -$0.92 10-Q · filed 2026-08-14 | ||||||||||||
| 2026-03-31 | -$0.20 10-Q · filed 2026-05-15 | |||||||||||||
| 2025-09-30 | -$9.10 10-Q · filed 2025-11-19 | -$47.49 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$72.94 10-Q · filed 2025-11-19 | |||||||||||
| 2025-06-30 | -$61.71 10-Q · filed 2026-08-14 | -$107.60 10-Q · filed 2026-08-14 | ||||||||||||
| 2025-03-31 | -$31.82 10-Q · filed 2026-05-15 | -$1.59 10-Q · filed 2025-05-15 | ||||||||||||
| 2024-12-31 | -$18.15 10-K · filed 2025-04-15 | |||||||||||||
| 2024-09-30 | -$170.22 10-Q · filed 2025-11-19 | -$0.09 10-Q/A · filed 2024-11-20 | -$405.42 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$560.27 10-Q · filed 2025-11-19 | -$0.28 10-Q/A · filed 2024-11-20 | |||||||||
| 2024-06-30 | -$302.32 10-Q · filed 2025-08-22 | -$0.15 10-Q · filed 2024-08-14 | -$531.35 10-Q · filed 2025-08-22 | -$0.27 10-Q · filed 2024-08-14 | ||||||||||
| 2024-03-31 | -$12.24 10-Q · filed 2025-05-15 | -$0.12 10-Q · filed 2024-05-17 | ||||||||||||
| 2024-02-13 | -$1959.63 10-Q · filed 2025-11-19 | -$0.06 10-Q · filed 2024-05-17 | ||||||||||||
| 2023-12-31 | -$1248.64 10-K · filed 2025-04-15 | |||||||||||||
| 2023-09-30 | -$0.15 10-Q/A · filed 2024-11-20 | -$0.67 10-Q/A · filed 2024-11-20 | ||||||||||||
| 2023-06-30 | -$0.23 10-Q · filed 2024-08-14 | -$0.50 10-Q · filed 2024-08-14 | ||||||||||||
| 2023-03-31 | -$0.27 10-Q · filed 2024-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |